Adjusting for differential rates of prophylaxis therapy for PCP in high- versus low-dose AZT treatment arms in an AIDS randomized trial

Abstract In the AIDS Clinical Trial Group randomized trial 002 comparing the effect of high-dose versus low-dose 3-azido-3-deoxythymidine (AZT) on the survival of acquired immunodeficiency syndrome (AIDS) patients, the median survival in the low-dose arm exceeded that in the high-dose arm. But subjects in the low-dose AZT arm received significantly more prophylaxis therapy for pneumocystis carinii pneumonia (PCP), a nonrandomized treatment, than those in the high-dose AZT arm. Thus the improved median survival in the low-dose arm might represent either the benefits associated with avoiding the toxicity of high-dose AZT therapy or the benefits of receiving prophylaxis therapy. The authors use structural nested failure time (SNFT) models to estimate the survival curves that would have been observed if the PCP prophylaxis experience in the high-dose and low-dose treatment arms had been similar. Our simplest models relate a subject's observed time of death and observed prophylaxis therapy to the time that the...

[1]  R. Prentice.  Linear rank tests with right censored data , 1978 .

[2]  J. Robins,et al.  Recovery of Information and Adjustment for Dependent Censoring Using Surrogate Markers , 1992 .

[3]  J. Robins.  A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods. , 1987, Journal of chronic diseases.

[4]  Terry M. Therneau,et al.  Use of Compliance Measures in an Analysis of the Effect of Diltiazem on Mortality and Reinfarction After Myocardial Infarction , 1993 .

[5]  J. Robins.  Correcting for non-compliance in randomized trials using structural nested mean models , 1994 .

[6]  S W Lagakos,et al.  Adjusting for early treatment termination in comparative clinical trials. , 1990, Statistics in medicine.

[7]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[8]  W. Newey,et al.  Semiparametric Efficiency Bounds , 1990 .

[9]  J. Robins,et al.  A method for the analysis of randomized trials with compliance information: an application to the Multiple Risk Factor Intervention Trial. , 1993, Controlled clinical trials.

[10]  J. Robins.  A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect , 1986 .

[11]  J. Robins.  The control of confounding by intermediate variables. , 1989, Statistics in medicine.

[12]  P. Spirtes,et al.  Causation, prediction, and search , 1993 .

[13]  Donald B. Rubin,et al.  Bayesian Inference for Causal Effects: The Role of Randomization , 1978 .

[14]  W. J. Hall,et al.  Information and Asymptotic Efficiency in Parametric-Nonparametric Models , 1983 .

[15]  M. Wulfsohn,et al.  A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome , 1990 .

[16]  J. Robins.  Addendum to “a new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect” , 1987 .

[17]  J. Pearl.  Causal diagrams for empirical research , 1995 .

[18]  J. Robins,et al.  Semiparametric Efficiency in Multivariate Regression Models with Missing Data , 1995 .

[19]  J. Robins,et al.  Correcting for non-compliance in randomized trials using rank preserving structural failure time models , 1991 .

[20]  J. V. Ryzin,et al.  Regression Analysis with Randomly Right-Censored Data , 1981 .

[21]  J. Robins,et al.  Estimating exposure effects by modelling the expectation of exposure conditional on confounders. , 1992, Biometrics.

[22]  J. Robins,et al.  Analysis of semiparametric regression models for repeated outcomes in the presence of missing data , 1995 .

[23]  J. Robins,et al.  G-Estimation of the Effect of Prophylaxis Therapy for Pneumocystis carinii Pneumonia on the Survival of AIDS Patients , 1992, Epidemiology.

[24]  H. Malani,et al.  A modification of the redistribution to the right algorithm using disease markers , 1995 .

[25]  D. Cox,et al.  Analysis of Survival Data. , 1985 .

[26]  J. Robins,et al.  Identifiability and Exchangeability for Direct and Indirect Effects , 1992, Epidemiology.

[27]  Zhiliang Ying,et al.  Linear regression analysis of censored survival data based on rank tests , 1990 .

[28]  J. Robins.  Estimation of the time-dependent accelerated failure time model in the presence of confounding factors , 1992 .

[29]  J. Robins,et al.  Estimating the causal effect of smoking cessation in the presence of confounding factors using a rank preserving structural failure time model. , 1993, Statistics in medicine.

[30]  B. Efron,et al.  Compliance as an Explanatory Variable in Clinical Trials , 1991 .

[31]  D. Cox.  Regression Models and Life-Tables , 1972 .

[32]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[33]  A Heyting,et al.  Statistical handling of drop-outs in longitudinal clinical trials. , 1992, Statistics in medicine.

[34]  Does depression cause heart disease? , 1993, Epidemiology.

[35]  Thomas A. Louis,et al.  Nonparametric analysis of an accelerated failure time model , 1981 .

[36]  P. Rosenbaum.  Conditional Permutation Tests and the Propensity Score in Observational Studies , 1984 .